Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Skye Bioscience Inc (NASDAQ: SKYE) closed at $4.26 in the last session, down -0.47% from day before closing price of $4.28. In other words, the price has decreased by -$0.47 from its previous closing price. On the day, 76133.0 shares were traded. SKYE stock price reached its highest trading level at $4.3437 during the session, while it also had its lowest trading level at $4.17.
Ratios:
We take a closer look at SKYE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.19 and its Current Ratio is at 14.19. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on September 30, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $20.
On September 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.
On July 09, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $18.Craig Hallum initiated its Buy rating on July 09, 2024, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Diep Tuan Tu sold 19,489 shares for $4.99 per share. The transaction valued at 97,250 led to the insider holds 82,259 shares of the business.
Diep Tuan Tu sold 85 shares of SKYE for $472 on Nov 15 ’24. The Chief Development Officer now owns 101,748 shares after completing the transaction at $5.55 per share. On Nov 18 ’24, another insider, ARSENAULT KAITLYN, who serves as the Chief Financial Officer of the company, sold 43,206 shares for $4.99 each. As a result, the insider received 215,598 and left with 166,342 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SKYE now has a Market Capitalization of 129241168 and an Enterprise Value of 62019496.
Stock Price History:
Over the past 52 weeks, SKYE has reached a high of $19.41, while it has fallen to a 52-week low of $1.44. The 50-Day Moving Average of the stock is -5.77%, while the 200-Day Moving Average is calculated to be -48.95%.
Shares Statistics:
According to the various share statistics, SKYE traded on average about 314.37K shares per day over the past 3-months and 173690 shares per day over the past 10 days. A total of 30.34M shares are outstanding, with a floating share count of 17.57M. Insiders hold about 42.09% of the company’s shares, while institutions hold 47.86% stake in the company. Shares short for SKYE as of 1731628800 were 1992030 with a Short Ratio of 6.34, compared to 1728950400 on 1417276. Therefore, it implies a Short% of Shares Outstanding of 1992030 and a Short% of Float of 9.819999.
